Clinical trials
Observational Hepatitis C trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 4 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 3 |
| Bristol-Myers Squibb | 2 |
| Fundación Pública Andaluza Progreso y Salud | 2 |
| Hepa C | 2 |
| Instituto de Investigación Marqués de Valdecilla | 2 |
| Valme University Hospital | 2 |
| Abbott Rapid Dx | 1 |
| Consorci Sanitari de l'Alt Penedès i Garraf | 1 |
| European Society for Blood and Marrow Transplantation | 1 |
| Fundacion IMIM | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 26 |
| Acquired Immunodeficiency Syndrome | 5 |
| Hepatitis C, Chronic | 5 |
| Hepatitis B | 4 |
| Carcinoma, Hepatocellular | 2 |
| Acidosis, Lactic | 1 |
| Cardiovascular Diseases | 1 |
| Coinfection | 1 |
| Communicable Diseases | 1 |
| Cytomegalovirus Infections | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.